1Fletcher EC, Lesske J, Qian W, et al. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension,1992,19(6 Pt 1) :555-561.
2Kang PM, Haunstetter A ,Aoki H, et al. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res,2000,87 :118-125.
3Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep,2002,25:59-65.
4Thackaberry EA, Gabaldon DM, Walker MK, et al. Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-lalpha in the absence of cardiac hypoxia.Cardiovasc Toxico1,2002 ,2 :263-274.
6Kanagy NL,Walker BR,Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension, 2001,37 ( 2 Part 2 ) :511-515.
7Lavie L, Hefetz A, Luboshitzky R, et al. Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment.J Mol Neurosci,2003,21:57-63.
8Barley J,Blackwood A,Carter N D,et al.Angiotensinconverting enzym e insertion/deletion polym orphis m : association withethnic origin. Journal of Hypertension . 1994
9Barley J,Blackwood A,Miller M,et al.Angiotensinconverting enzym e gene I/ D poly morphism , blood pressure and thereninangiotensin system in Caucasian and Afro Caribbean peoples. Journal of Hypertension . 1996
10Tiret L. Rigat B,Visvikis S,et al.Evidence ,from com binedsegregation and linkage analysis , that a variant of the angiotensinⅠconverting enzym e ( A C E) gene controls plasma A C Elevels. Am J Hu m Genet . 1992
